Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

ClinicalTrials.gov ID: NCT03354273

Public ClinicalTrials.gov record NCT03354273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-Label, Multicentre Study of Flurpiridaz (18F) Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coronary Angiography Because of Suspected Coronary Artery Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, prospective, open-label, international, multicentre study of Flurpiridaz (18F) Injection for PET MPI in patients referred for ICA because of suspected CAD.

Study identification

NCT ID
NCT03354273
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GE Healthcare
Industry
Enrollment
730 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 5, 2018 (Actual)
Primary completion
May 5, 2022 (Actual)
Completion
May 5, 2022 (Actual)
Last update posted
Jul 12, 2023

2018 – 2022

United States locations

U.S. sites
37
U.S. states
16
U.S. cities
29
Facility City State ZIP Site status
Vascular Biology and Hypertension Program, University of Alabama at Birmingham Birmingham Alabama 35294 —
University of California- Los Angeles Los Angeles California 90024 —
Keck Hospital of USC Los Angeles California 90033 —
VA Greater Los Angeles Health Care System Los Angeles California 90073 —
VA San Diego Health System San Diego California 92161 —
UCSF San Francisco California 94107 —
Tower Saint John's Imaging Santa Monica California 90403 —
Yale New Haven Hospital New Haven Connecticut 06510 —
Cardiology Physicians PA/Red Clay Research LLC Newark Delaware 19713 —
University of Florida Gainesville Florida 32610 —
Indago Research and Health Center Hialeah Florida 33012 —
Optimus U Corp Miami Florida 33125 —
Infinite Clinical Research Miami Florida 33133-4214 —
Allied Biomedical Research Institute Miami Florida 33155 —
Comprehensive Vascular Care PA Miami Florida 33155 —
Amavita Clinical Research, LLC North Miami Beach Florida 33169 —
Emory University Atlanta Georgia 30322 —
University Of Iowa Hospitals And Clinics Iowa City Iowa 52242 —
Midwest Heart and Vascular Specialists Overland Park Kansas 66211 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Saint Luke's Hospital of Kansas City Kansas City Missouri 64111 —
VA St. Louis Health Care System St Louis Missouri 63106 —
St Louis University St Louis Missouri 63110 —
Washington University School of Medicine St Louis Missouri 63110 —
Columbia University Medical Center/New York Presbyterian Hospital - Milstein Hospital Building New York New York 10032 —
University of Cincinnati Medical Center Cincinnati Ohio 45219 —
OhioHealth Research Institute Columbus Ohio 43214 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Berks Cardiologists, LTD Wyomissing Pennsylvania 19610 —
University of Tennessee Medical Center Knoxville Tennessee 37920 —
VA North Texas Health Care System - NAVREF - PPDS Dallas Texas 75216 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
The Methodist Hospital Research Institute Houston Texas 77030 —
Vital Heart & Vein Humble Texas 77338 —
Memorial City and Katy Cardiology Associates Katy Texas 77493 —
University of Virginia Health System Charlottesville Virginia 22908 —
Roanoke Heart Institute Roanoke Virginia 24014 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03354273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 12, 2023 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03354273 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →